Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-02 Purchase |
2020-11-04 4:19 pm |
LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director |
1,000 | $82.52 | $82,520 | 28,190 (Direct) |
View |
| 2020-08-26 Sale(A) |
2020-08-28 5:11 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) |
View |
| 2020-08-25 Sale |
2020-08-27 7:06 pm |
Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner |
164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) |
View |
| 2020-08-21 Sale |
2020-08-25 7:10 pm |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
7,303 | $112.86 | $824,190 | 284,170 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A 2027-05-25 |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $0 | 52,761 (Direct) |
View |
| 2021-01-27 Exercise |
2021-01-27 7:02 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director |
2,456 | $113.5 | 52,761 (Direct) |
View |
| 2020-12-31 Other |
2021-01-05 8:30 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
223 | $84.53 | 235,533 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-09 6:12 pm |
N/A 2021-02-17 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
14,657 | $0 | 295,087 (Direct) |
View |
| 2020-12-08 Exercise |
2020-12-09 6:12 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
14,657 | $10.05 | 295,087 (Direct) |
View |
| 2020-12-08 Tax Withholding |
2020-12-09 6:12 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
1,683 | $87.52 | 295,087 (Direct) |
View |
| 2020-11-09 Tax Withholding |
2020-11-10 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
2,458 | $81.77 | 296,770 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 7:41 pm |
N/A 2021-02-17 |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,000 | $0 | 296,770 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 7:41 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L Chief Executive Officer |
20,000 | $10.05 | 296,770 (Direct) |
View |
Ownership |
2020-10-09 06:30 am |
N/A N/A |
Pfenex Inc. | PFNX | LIGAND PHARMACEUTICALS INC 10% Owner |
0 | $0 | 27,034,437 (Direct) |
View |
| 2020-08-24 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
78 | $21.92 | 284,170 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
790 | $74.42 | 284,170 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A 2022-02-09 |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
8,093 | $0 | 284,170 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-25 7:10 pm |
N/A N/A |
LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W President and COO |
7,225 | $14.47 | 284,170 (Direct) |
View |